Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2026-01-11 @ 8:09 AM
Study NCT ID:
NCT05155566
Status:
COMPLETED
Last Update Posted:
2024-01-26
First Post:
2021-12-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-12
Completion Date Type:
ACTUAL
First Submit Date:
2021-12-09
First Submit QC Date:
None
Study First Post Date:
2021-12-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-03-11
Results First Submit QC Date:
None
Results First Post Date:
2024-01-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-15
Last Update Post Date:
2024-01-26
Last Update Post Date Type:
ACTUAL